Furthermore, taking into account the status of the FGFR4 p.Gly388Arg allele, this polymporphism can be considered to be a novel alternative for predicting clinical development and assessing the stage of disease in patients with advanced stage retinoblastoma. The gene discussed is FGFR4; the disease is retinoblastoma.